Format

Send to

Choose Destination
Exp Neurol. 2016 May;279:178-186. doi: 10.1016/j.expneurol.2016.02.021. Epub 2016 Mar 2.

Cognitive impairments following cranial irradiation can be mitigated by treatment with a tropomyosin receptor kinase B agonist.

Author information

1
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA; Palo Alto Veterans Institute for Research, Palo Alto, CA 94304, USA.
2
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.
3
Department of Chemistry and Biochemistry, California State University Fullerton, CA 92831, USA.
4
Brain and Spinal Injury Center, Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA.
5
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA; Geriatric Research, Education, and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA. Electronic address: tthuang@stanford.edu.

Abstract

Brain radiotherapy is frequently used successfully to treat brain tumors. However, radiotherapy is often associated with declines in short-term and long-term memory, learning ability, and verbal fluency. We previously identified a downregulation of the brain-derived neurotrophic factor (BDNF) following cranial irradiation in experimental animals. In the present study, we investigated whether targeting the BDNF high affinity receptor, tropomysin receptor kinase B (TrkB), could mitigate radiation-induced cognitive deficits. After irradiation, chronic treatment with a small molecule TrkB agonist, 7,8-dihydroxyflavone (DHF) in mice led to enhanced activation of TrkB and its downstream targets ERK and AKT, both important factors in neuronal development. DHF treatment significantly restored spatial, contextual, and working memory, and the positive effects persisted for at least 3months after completion of the treatment. Consistent with preservation of cognitive functions, chronic DHF treatment mitigated radiation-induced suppression of hippocampal neurogenesis. Spine density and major components of the excitatory synapses, including glutamate receptors and postsynaptic density protein 95 (PSD-95), were also maintained at normal levels by DHF treatment after irradiation. Taken together, our results show that chronic treatment with DHF after irradiation significantly mitigates radiation-induced cognitive defects. This is achieved most likely by preservation of hippocampal neurogenesis and synaptic plasticity.

KEYWORDS:

Cognitive function; Hippocampus; Irradiation; Neurogenesis; Synaptic plasticity; TrkB

PMID:
26946222
PMCID:
PMC4933026
DOI:
10.1016/j.expneurol.2016.02.021
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center